Occludin deficiency with BACE1 elevation in cerebral amyloid angiopathy

Neurology

Volumn 82, Issue 19, 2014, Pages 1707-1715

  Cheng, Xin ^a,b   He, Ping ^b,c   Yao, Hailan ^e   Dong, Qiang ^a   Li, Rena ^c   Shen, Yong ^a,b,c,d  

^a FUDAN UNIVERSITY   (China)

^b SUN HEALTH RESEARCH INSTITUTE   (United States)

^c ROSKAMP INSTITUTE   (United States)

^d UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^e Department of Neurology University of Florida College of Medicine ^*

Author keywords

[No Author keywords available]

Indexed keywords

BETA SECRETASE 1; OCCLUDIN;

AGED; ARTERY; ARTICLE; AUTOPSY; BLOOD VESSEL; BRAIN; BRAIN BLOOD VESSEL; BRAIN CORTEX; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICAL VESSEL; CYTOLOGY; ENDOTHELIUM CELL; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEPTOMENINGEAL VESSEL; MALE; MOLECULAR BIOLOGY; NERVE CELL; OCCLUDIN DEFICIENCY; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; TIGHT JUNCTION; VASCULAR AMYLOIDOSIS; VERY ELDERLY;

AGED; AGED, 80 AND OVER; AMYLOID PRECURSOR PROTEIN SECRETASES; ASPARTIC ACID ENDOPEPTIDASES; CASE-CONTROL STUDIES; CEREBRAL AMYLOID ANGIOPATHY; CEREBRAL ARTERIES; CEREBRAL CORTEX; FEMALE; HUMANS; MALE; MENINGES; OCCLUDIN;

EID: 84902134550     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000000403     Document Type: Article

References (35)

1. Greenberg SM. Cerebral amyloid angiopathy: prospects for clinical diagnosis and treatment. Neurology 1998;51:690-694.
2. Biffi A, Anderson CD, Jagiella JM, et al. APOE genotype and extent of bleeding and outcome in lobar intracerebral haemorrhage: a genetic association study. Lancet Neurol 2011;10:702-709.
3. Ellis RJ, Olichney JM, Thal LJ, et al. Cerebral amyloid angiopathy in the brains of patients with Alzheimer's disease: the CERAD experience, part XV. Neurology 1996; 46:1592-1596.
4. Vassar R, Bennett BD, Babu-Khan S, et al. Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science 1999; 286:735-741.
5. Sinha S, Anderson JP, Barbour R, et al. Purification and cloning of amyloid precursor protein beta-secretase from human brain. Nature 1999;402:537-540.
6. Yan R, Bienkowski MJ, Shuck ME, et al. Membraneanchored aspartyl protease with Alzheimer's disease betasecretase activity. Nature 1999;402:533-537.
7. Yang LB, Lindholm K, Yan R, et al. Elevated betasecretase expression and enzymatic activity detected in sporadic Alzheimer disease. Nat Med 2003;9:3-4.
8. Fukumoto H, Cheung BS, Hyman BT, Irizarry MC. Betasecretase protein and activity are increased in the neocortex in Alzheimer disease. Arch Neurol 2002;59:1381-1389.
9. Holsinger RM, McLean CA, Beyreuther K, Masters CL, Evin G. Increased expression of the amyloid precursor beta-secretase in Alzheimer's disease. Ann Neurol 2002; 51:783-786.
10. Tesco G, Koh YH, Kang EL, et al. Depletion of GGA3 stabilizes BACE and enhances beta-secretase activity. Neuron 2007;54:721-737.
11. Hunter JM, Kwan J, Malek-Ahmadi M, et al. Morphological and pathological evolution of the brain microcirculation in aging and Alzheimer's disease. PLoS One 2012;7: e36893.
12. Okazaki H, Reagan TJ, Campbell RJ. Clinicopathologic studies of primary cerebral amyloid angiopathy. Mayo Clin Proc 1979;54:22-31.
13. Beach TG, Sue LI, Walker DG, et al. The Sun Health Research Institute Brain Donation Program: description and experience, 1987-2007. Cell Tissue Bank 2008;9:229-245.
14. Vonsattel JP, Myers RH, Hedley-Whyte ET, Ropper AH, Bird ED, Richardson EP Jr. Cerebral amyloid angiopathy without and with cerebral hemorrhages: a comparative histological study. Ann Neurol 1991;30:637-649.
15. Roher AE, Kuo YM, Esh C, et al. Cortical and leptomeningeal cerebrovascular amyloid and white matter pathology in Alzheimer's disease. Mol Med 2003;9:112-122.
16. Li R, Lindholm K, Yang LB, et al. Amyloid beta peptide load is correlated with increased beta-secretase activity in sporadic Alzheimer's disease patients. Proc Natl Acad Sci USA 2004;101:3632-3637.
17. He P, Zhong Z, Lindholm K, et al. Deletion of tumor necrosis factor death receptor inhibits amyloid beta generation and prevents learning and memory deficits in Alzheimer's mice. J Cell Biol 2007;178:829-841.
18. Zhong Z, Ewers M, Teipel S, et al. Levels of beta-secretase (BACE1) in cerebrospinal fluid as a predictor of risk in mild cognitive impairment. Arch Gen Psychiatry 2007;64:718-726.
19. Chirapu SR, Pachaiyappan B, Nural HF, et al. Molecular modeling, synthesis, and activity studies of novel biaryl and fused-ring BACE1 inhibitors. Bioorg Med Chem Lett 2009;19:264-274.
20. Hyman BT, Phelps CH, Beach TG, et al. National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease. Alzheimers Dement 2012;8:1-13.
21. Austin SA, Santhanam AV, Katusic ZS. Endothelial nitric oxide modulates expression and processing of amyloid precursor protein. Circ Res 2010;107:1498-1502.
22. Shen Y, He P, Cheng X, Ewers M, et al. Plasma BACE1 levels are increased in patients of mild cognitive impairment and Alzheimer's disease. Alzheimer's Association 13th International Conference on Alzheimer's Disease and Related Disorders; 2011; Paris.
23. Zlokovic BV. The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron 2008;57:178-201.
24. Carrano A, Hoozemans JJ, van der Vies SM, Rozemuller AJ, van Horssen J, de Vries HE. Amyloid beta induces oxidative stress-mediated blood-brain barrier changes in capillary amyloid angiopathy. Antioxid Redox Signal 2011;15:1167-1178.
25. Tai LM, Holloway KA, Male DK, Loughlin AJ, Romero IA. Amyloid-beta-induced occludin downregulation and increased permeability in human brain endothelial cells is mediated by MAPK activation. J Cell Mol Med 2010;14:1101-1112.
26. Cai H, Wang Y, McCarthy D, et al. BACE1 is the major beta-secretase for generation of Abeta peptides by neurons. Nat Neurosci 2001;4:233-234.
27. Luo Y, Bolon B, Kahn S, et al. Mice deficient in BACE1, the Alzheimer's beta-secretase, have normal phenotype and abolished beta-amyloid generation. Nat Neurosci 2001;4:231-232.
28. Hu X, Hicks CW, He W, et al. Bace1 modulates myelination in the central and peripheral nervous system. Nat Neurosci 2006;9:1520-1525.
29. Seshadri S, Kamiya A, Yokota Y, et al. Disrupted-inschizophrenia- 1 expression is regulated by beta-site amyloid precursor protein cleaving enzyme-1-neuregulin cascade. Proc Natl Acad Sci USA 2010;107:5622-5627.
30. Zhao J, O'Connor T, Vassar R. The contribution of activated astrocytes to Abeta production: implications for Alzheimer's disease pathogenesis. J Neuroinflammation 2011;8:150.
31. Cheng X, He P, Lee T, Yao H, Li R, Shen Y. High activities of BACE1 in brains with mild cognitive impairment. Am J Pathol 2014;184:141-147.
32. Carrano A, Hoozemans JJ, van der Vies SM, van Horssen J, de Vries HE, Rozemuller AJ. Neuroinflammation and blood-brain barrier changes in capillary amyloid angiopathy. Neurodegener Dis 2012;10:329-331.
33. Hartz AM, Bauer B, Soldner EL, et al. Amyloid-beta contributes to blood-brain barrier leakage in transgenic human amyloid precursor protein mice and in humans with cerebral amyloid angiopathy. Stroke 2012;43:514-523.
34. Chen YW, Gurol ME, Rosand J, et al. Progression of white matter lesions and hemorrhages in cerebral amyloid angiopathy. Neurology 2006;67:83-87.
35. Kimberly WT, Gilson A, Rost NS, et al. Silent ischemic infarcts are associated with hemorrhage burden in cerebral amyloid angiopathy. Neurology 2009;72:1230-1235.